Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $1.4B bought by 281 insiders at 188 companies
- $2.3B sold by 265 insiders outside a trading plan
- $3.1B sold by 585 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$124M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$115M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$54M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
-
COURCoursera, Inc.Pale Fire Capital SE10% owner · +4 joint filers$11.4M
-
CVCapsoVision, Inc.Eliyahou Et Al Harari10% owner$10M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
CRWDCrowdStrike Holdings, Inc.Burt W. PodbereCFO$134M
-
MEDPMedpace Holdings, Inc.August J. TroendleCEO$126M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
BZKanzhun LimitedPeng Jonathan ZhaoCEO$110M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Nikolaos Reskos COO, Charis Plakantonaki Chief Strategy Officer
-
Joseph D Sarafa Director, Brian J Roney CEO, James Grant Smith Director, Harold J Meloche CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
-
Michael Jordan Osborn CEO, Gregory William Voorhies Director, Chris Riccardi Director, James W Bernau President
-
J Tutt Barrett Director, David E Housel Director, William F Ham Jr. Director, Shannon O'Donnell Senior Vice President
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Peter Altman CEOBCDABioCardia, Inc.Buy$1,030 1,000 shares at $1.03 +0.3% to stakeTraded Sep 29 Filed Sep 30
-
Laura Lee Stewart CEOSFBCSound Financial Bancorp, Inc.Planned sale$41K 900 shares at $45.99 10% of stakeTraded Sep 30 Filed Sep 30
-
Michael Hsing CEOMPWRMonolithic Power Systems, Inc.Planned sale$40.3M 30,000 shares at $1,344.97 3.5% of stakeTraded Sep 28 Filed Sep 30
-
John Taylor Maloney Fitzgerald CEOKWYKingsway CorporationBuy$2,502 269 shares at $9.30 +<0.1% to stakeTraded Sep 30 Filed Sep 30
-
D James Bidzos CEOVRSNVerisign Inc.Planned sale$920K 3,300 shares at $278.78 0.9% of stakeTraded Sep 29 Filed Sep 30
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $477.42 2.8% of stakeTraded Sep 29 Filed Sep 30
-
William B. Horne CEOGPUSHyperscale Data, Inc.Buy$16K 100,000 shares at $0.1600 +25% to stakeTraded Sep 30 Filed Sep 30
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.5M 66,000 shares at $98.19 24% of stakeTraded Sep 29–30 Filed Sep 30
-
Richard Barry CEOFLNAFilana Therapeutics, Inc.Buy$78K 93,091 shares at $0.8400 +9.9% to stakeTraded Sep 28 Filed Sep 30
-
Kevin J McNamara CEOCHEChemed Corp.Sale$1M 2,000 shares at $513.45 2.9% of stakeTraded Sep 28 Filed Sep 30
-
Richard H Moore CEOFBNCFirst BancorpSale$1.5M 23,343 shares at $62.85 22% of stakeTraded Sep 28–29 Filed Sep 30
-
Robert George Culp IV CEOCULPCulp, Inc.Buy$12K 2,960 shares at $3.89 +2.2% to stakeTraded Sep 28 Filed Sep 30
-
Kun Dai CEOUXINUxin LimitedBuy$11K 8,440 shares at $1.26 New stakeTraded Sep 29 Filed Sep 30
-
Joseph P. Davy CEOPARABanzai International, Inc.Buy— 115,965 shares +343% to stakeTraded Sep 28 Filed Sep 30
-
Philip Andrew Smith CEOSNEXStoneX Group Inc.Planned sale$3.7M 56,250 shares at $65.69 7.1% of stakeTraded Sep 28 Filed Sep 29
-
Jayshree Ullal CEOANETArista Networks, Inc.Planned sale$13.2M 62,622 shares at $211.40 0.4% of stakeTraded Sep 25 Filed Sep 29
-
Robert Thomas Dechant CEOIBEXIBEX LimitedPlanned sale$225K 5,000 shares at $45.02 1.9% of stakeTraded Sep 25 Filed Sep 29
-
Michael Edell CEOSNESSenesTech, Inc.Buy$1,289 2,000 shares at $0.6400 +22% to stakeTraded Sep 28 Filed Sep 29
-
Ryan Cohen CEOGMEGameStop CorporationBuy$10.6M 450,000 shares at $23.48 +1.1% to stakeTraded Sep 29 Filed Sep 29
-
William B. Horne CEOGPUSHyperscale Data, Inc.Buy$17K 100,000 shares at $0.1700 +33% to stakeTraded Sep 29 Filed Sep 29
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.6M 9,500 shares at $480.85 2.8% of stakeTraded Sep 28 Filed Sep 29
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$1.6M 2,564 shares at $620.10 0.7% of stakeTraded Sep 25–28 Filed Sep 29
-
Ross Dove CEOHGBLHeritage Global Inc.Sale$399K 300,000 shares at $1.33 13% of stakeTraded Sep 25 Filed Sep 29
-
Yongdong Peng CEOBEKEKE Holdings IncSale$84.6M 16M shares at $5.27 20% of stakeTraded Sep 25 Filed Sep 29
-
Chandler Robinson CEOMNPRMonopar Therapeutics Inc.Planned sale$2.6M 29,056 shares at $88.00 23% of stakeTraded Sep 24 Filed Sep 28
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.2M 20,000 shares at $258.12 0.3% of stakeTraded Sep 24–25 Filed Sep 28
-
Mark Zuckerberg CEOMETAMeta Platforms, Inc., Class APlanned sale$21.4M 27,474 shares at $777.44 2.2% of stakeTraded Sep 24 Filed Sep 28
-
Mark Lappe CEOINBXInhibrx Biosciences, Inc.Buy$999K 10,000 shares at $99.88 +1.4% to stakeTraded Sep 25–28 Filed Sep 28
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6M 61,000 shares at $98.57 18% of stakeTraded Sep 25–28 Filed Sep 28
-
Benjamin J Bochnowski CEOFNWDFinward BancorpBuy$224 5 shares at $43.48 +0.3% to stakeTraded Sep 25 Filed Sep 28
-
Robert I Blum CEOCYTKCytokinetics, IncorporatedPlanned sale$491K 7,500 shares at $65.46 2.6% of stakeTraded Sep 28 Filed Sep 28
-
William O'Dowd IV CEODLPNDolphin Entertainment, Inc.Buy$4,884 4,400 shares at $1.11 +0.8% to stakeTraded Sep 28 Filed Sep 28
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $476.17 2.8% of stakeTraded Sep 25 Filed Sep 28
-
George Kurian CEONTAPNetApp, Inc.Planned sale$7.4M 37,000 shares at $199.95 12% of stakeTraded Sep 24 Filed Sep 28
-
Luis Von Ahn CEODUOLDuolingo, Inc.Planned sale$7M 46,682 shares at $150.63 100% of stakeTraded Sep 24 Filed Sep 28
-
Amit Kumar CEOANIXAnixa Biosciences, Inc.Buy$19K 7,000 shares at $2.78 +1.1% to stakeTraded Sep 24 Filed Sep 28
-
Jennifer Jarrett CEODMRADamora Therapeutics, Inc.Buy$253K 12,500 shares at $20.23 +2.5% to stakeTraded Sep 25 Filed Sep 28
-
Luis A Muller CEOCOHUCohu, Inc.Planned sale$1.8M 27,236 shares at $65.00 3.1% of stakeTraded Sep 25 Filed Sep 25
-
Rajeev K. Goel CEOPUBMPubMatic, Inc.Planned sale$931K 50,453 shares at $18.45 100% of stakeTraded Sep 24 Filed Sep 25
-
Cristiano R Amon CEOQCOMQUALCOMM IncorporatedPlanned sale$2M 10,000 shares at $200.00 5.3% of stakeTraded Sep 25 Filed Sep 25
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.5M 9,500 shares at $473.55 2.8% of stakeTraded Sep 24 Filed Sep 25
-
August J. Troendle CEOMEDPMedpace Holdings, Inc.Sale$27.4M 43,916 shares at $624.01 10% of stakeTraded Sep 23–24 Filed Sep 25
-
Ronald W Hovsepian CEOSKILSkillsoft Corp.Buy$66K 11,196 shares at $5.93 +3% to stakeTraded Sep 23 Filed Sep 25
-
Douglas Love CEOANNXAnnexon, Inc.Buy$100K 26,065 shares at $3.83 +7.2% to stakeTraded Sep 24 Filed Sep 25
-
Chae Lee CEOMXMagnachip Semiconductor CorporationBuy$318K 100,000 shares at $3.18 +35% to stakeTraded Sep 23–24 Filed Sep 25
-
Olivier Loeillot CEORGENRepligen CorporationPlanned sale$2.5M 12,946 shares at $190.00 21% of stakeTraded Sep 24 Filed Sep 25
-
Emily M. Leproust CEOTWSTTwist Bioscience CorporationPlanned sale$923K 5,203 shares at $177.38 0.8% of stakeTraded Sep 24 Filed Sep 25
-
Laurel Hurd CEOTILEInterface, Inc.Planned sale$245K 7,000 shares at $34.99 1.4% of stakeTraded Sep 24 Filed Sep 25
-
Paul W Nester CEORGCORGC Resources Inc.Buy$6,324 300 shares at $21.08 +0.2% to stakeTraded Sep 23 Filed Sep 25
-
Or Offer CEOSMWBSimilarweb Ltd.Planned sale$879K 114,300 shares at $7.69 2.8% of stakeTraded Sep 24 Filed Sep 25
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.